C

CareDx
D

CDNA

23.178
USD
0.54
(2.38%)
مغلق
حجم التداول
24,250
الربح لكل سهم
-0
العائد الربحي
-
P/E
-9
حجم السوق
1,243,125,862
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACU
    -0.990
    (-2.64%)
    36.510 USD
    B
    BCRX
    0.01500
    (0.20%)
    7.62000 USD
    C
    CMP
    -0.180
    (-1.30%)
    13.690 USD
    C
    CRIS
    -0.16000
    (-4.68%)
    3.26000 USD
    NTR
    NTR
    1.290
    (2.52%)
    52.570 USD
    المزيد
الأخبار
المقالات

العنوان: CareDx

القطاع: Healthcare
الصناعة: Diagnostics & Research
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.